Background illustration for clinical trials search

Paid Clinical Trials Provo

Discover 1,057 paid clinical trials in Provo, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for
Neutropenia
Location: Salt Lake City UT, Phoenix AZ, Los Angeles CA,
Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase 3, Recruiting

Telerehabilitation for Patients With Chronic Low Back Pain (TeleBACK Clinical Trial)

for
Chronic Low Back Pain
Location: Salt Lake City UT, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 64

Code: NCT06821607

Recruiting

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

for
Cerebral Palsy
Location: Salt Lake City UT, Atlanta GA, Baltimore MD,
Sponsor: Emory University

Sex: All

Age: 0 - 1

Code: NCT04997109

Recruiting

Stroke Thrombectomy and Aneurysm Registry

for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Salt Lake City UT, Loma Linda CA, Santa Barbara CA,
Sponsor: Medical University of South Carolina

Sex: All

Age: 1 - 70+

Code: NCT04994756

Recruiting

Risk of Recurrent CeAD After Pregnancy

for
Cervical Artery Dissection, Pregnancy Complications
Location: Salt Lake City UT, Charlottesville VA
Sponsor: University Hospital, Basel, Switzerland

Sex: Female

Age: 18+

Code: NCT06258109

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

for
Chemotherapy-induced Peripheral Neuropathy
Location: Salt Lake City UT, Richmond VA, Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT04763356

Recruiting

Remission From Stage D Heart Failure

for
Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Location: Salt Lake City UT, Omaha NE, Louisville KY,
Sponsor: University of Louisville

Sex: All

Age: 18 - 59

Code: NCT01774656

Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Salt Lake City UT, San Francisco CA, Rochester MN,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase 1, Recruiting

Cardiac Sarcoidosis Randomized Trial

for
Cardiac Sarcoidosis, Sarcoidosis
Location: Salt Lake City UT, Calgary, Vancouver, Ann Arbor MI,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18+

Code: NCT03593759

Phase 3, Recruiting

Proton or Photon RT for Retroperitoneal Sarcomas

for
Retroperitoneal Sarcoma
Location: Salt Lake City UT, Rochester MN, Creve Coeur MO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT01659203

Phase 1, Phase 2, Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: Salt Lake City UT, Orange CA, Seattle WA, Omaha NE,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase 3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Salt Lake City UT, Grand Junction CO, Cedar City UT,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

for
Vanishing White Matter Disease
Location: Salt Lake City UT, Philadelphia PA, Montreal, Boston MA
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 0+

Code: NCT05757141

Phase 1, Phase 2, Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: Salt Lake City UT, Denver CO, Tucson AZ, Long Beach CA,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase 1, Phase 2, Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Salt Lake City UT, Aurora CO, Duarte CA, Los Angeles CA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase 3, Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for
SLE, SLE (Systemic Lupus)
Location: Salt Lake City UT, Avondale AZ, Tucson AZ, Plano TX,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT06613360

Phase 1, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Smith UT, Salt Lake City UT, Ogden UT,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Salt Lake City UT, Phoenix AZ, Portland OR,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase 1, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Salt Lake City UT, Duarte CA, Los Angeles CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase 3, Recruiting

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

for
Glycogen Storage Disease Type II Infantile Onset
Location: Salt Lake City UT, Cincinnati OH, Atlanta GA,
Sponsor: Amicus Therapeutics

Sex: All

Age: 0 - 17

Code: NCT04808505

Phase 3, Recruiting